WOCKPHARMA2022-01-012022-03-31in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2022-01-012022-03-31in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2022-01-012022-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2022-01-012022-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2022-01-012022-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2022-01-012022-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2021-04-01 2022-03-31 2022-05-23 INR Crores Yearly true Cash Flow Indirect Single segment Pharmaceuticals 2022-01-01 2022-03-31 Audited Consolidated 6550000000.00 140000000.00 6690000000.00 1610000000.00 1160000000.00 -20000000.00 1810000000.00 860000000.00 590000000.00 2320000000.00 8330000000.00 -1640000000.00 -1830000000.00 -3470000000.00 10000000.00 -370000000.00 -360000000.00 0.00 -3110000000.00 0.00 0.00 0.00 0.00 -3110000000.00 -50000000.00 -3160000000.00 -2580000000.00 -530000000.00 -2700000000.00 -460000000.00 720000000.00 5 -21.20 -21.20 0.00 0.00 -21.20 -21.20 Notes To consolidated Results:- 1. For Notes to Consolidated Results please refer the notes from the Statement of Consolidated Audited Results for the quarter and year ended March 31, 2022 as attached which is submitted under Outcome of Board Meeting yesterday. 2. Current tax for the quarter and year ended March 31, 2022 includes tax pertaining to earlier years. 3. EPS for the quarter ended March 31, 2022 is not annualised. Notes to Cash Flow Statements 1. For Notes to Cash flow statement, please refer Audited Results for the quarter and year ended March 31, 2022 as attached which is submitted under Outcome of Board Meeting yesterday 2. Proceeds from excercise of Stock Options is Rs. 0.02 crore being Proceeds from Issuance of Equity share capital under ESOP. 3.Proceeds from issuance of shares includes Rs. 747 crore net proceeds from issuance of equity shares under Right Issue after deducting transaction cost relating to Right Issue of Rs. 1 Crore. 4. Proceeds from borrowing includes proceeds from long term borrowings Rs. 49 crore and loan from Related Parties Rs. 1,348 crore. 5. Repayment from borrowing includes repayment of long term borrowings Rs. 786 crore, short term borrowings (net ) Rs. 101 crore and repayment of loan taken from Related Parties Rs. 1,302 crore. 6. Aggregated/segregated in accordance with the prescribed format and to the extent is the requirement of the accounting standard. Single segment 2021-04-01 2022-03-31 Audited Consolidated 32300000000.00 200000000.00 32500000000.00 6120000000.00 5680000000.00 870000000.00 7490000000.00 2990000000.00 2470000000.00 9160000000.00 34780000000.00 -2280000000.00 -1830000000.00 -4110000000.00 380000000.00 -1700000000.00 -1320000000.00 0.00 -2790000000.00 0.00 0.00 0.00 0.00 -2790000000.00 -270000000.00 -3060000000.00 -2440000000.00 -350000000.00 -2760000000.00 -300000000.00 720000000.00 5 37770000000.00 -20.24 -20.24 0.00 0.00 -20.24 -20.24 Other Expenses 2320000000.00 Other Expenses 9160000000.00 2990000000.00 300000000.00 70000000.00 0.00 -1130000000.00 0.00 0.00 0.00 0.00 4570000000.00 0.00 0.00 0.00 2470000000.00 0.00 0.00 0.00 0.00 0.00 -110000000.00 0.00 60000000.00 10000000.00 0.00 0.00 0.00 0.00 100000000.00 0.00 9210000000.00 5100000000.00 0.00 0.00 0.00 970000000.00 0.00 4130000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10000000.00 1180000000.00 0.00 0.00 0.00 940000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 30000000.00 0.00 70000000.00 0.00 -2010000000.00 0.00 0.00 7470000000.00 0.00 0.00 0.00 0.00 2370000000.00 13970000000.00 21890000000.00 0.00 710000000.00 0.00 1900000000.00 0.00 -20000000.00 -710000000.00 1410000000.00 -30000000.00 1380000000.00 2320000000.00 3700000000.00